{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:42:09Z","timestamp":1788576129213,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006096","name":"Shiraz Transplant Research Center, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["11823"],"award-info":[{"award-number":["11823"]}],"id":[{"id":"10.13039\/501100006096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.actatropica.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:22:31Z","timestamp":1525436551000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes"],"prefix":"10.1016","volume":"185","author":[{"given":"R.","family":"Nazari-Vanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Dehdari","family":"Vais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sattarahmady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Karimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Motazedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Heli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2018.05.002_bib0005","first-page":"92","article-title":"Prevalence of visceral leishmaniasis in hospitalized patients as an increasing public health problem","volume":"3","author":"Abazaj","year":"2016","journal-title":"J. Microbiol. Exp."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0010","first-page":"69","article-title":"Comparison of PCR assays with direct microscopy for diagnosis of cutaneous leishmaniasis patients reported from Sindh, Pakistan","author":"Ali","year":"2014","journal-title":"IEEE"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0378-4347(00)84319-4","article-title":"Determination of the antifungal agent, ketoconazole, in human plasma by high-performance liquid chromatography","volume":"221","author":"Alton","year":"1980","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1208\/s12249-014-0141-8","article-title":"Vancomycin-eluting niosomes: a new approach to the inhibition of staphylococcal biofilm on abiotic surfaces","volume":"15","author":"Barakat","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.948742","article-title":"Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro","volume":"193","author":"Chang","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0035","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.7403880","article-title":"Human cutaneous lieshmania in a mouse macrophage line: propagation and isolation of intracellular parasites","volume":"209","author":"Chang","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bpc.2016.07.005","article-title":"Miltefosine-loaded lipid nanoparticles: improving miltefosine stability and reducing its hemolytic potential toward erythtocytes and its cytotoxic effect on macrophages","volume":"217","author":"da Gama Bitencourt","year":"2016","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/pat.1710","article-title":"Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation","volume":"22","author":"Das","year":"2011","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0050","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00726-013-1661-3","article-title":"A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48\u201360) peptide favors intracellular delivery and visualization of the antiparasitic drug","volume":"46","author":"de la Torre","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"22","author":"David","year":"2009","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.exppara.2011.05.009","article-title":"Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis","volume":"128","author":"Eissa","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"Goto","year":"2010","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0070","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1166\/nnl.2016.2274","article-title":"Characterization of elastic niosomes prepared with various nonionic surfactants for lidocaine hydrochloride transdermal delivery","volume":"8","author":"Guan","year":"2016","journal-title":"Nanosci. Nanotechnol. Lett."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0075","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.apjtm.2017.10.016","article-title":"Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: an update","volume":"10","author":"Gutierrez-Rebolledo","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-018-2128-6","article-title":"In vitro antileishmanial and cytotoxicity activities of essential oils from Haplophyllum tuberculatum A. Juss leaves, stems and aerial parts","volume":"18","author":"Hamdi","year":"2018","journal-title":"BMC Complement. Altern. Med"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0781.2010.00536.x","article-title":"Photonanodermatology: the interface of photobiology, dermatology and nanotechnology","volume":"27","author":"Hia","year":"2011","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0090","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","article-title":"Spanlastics\u2013a novel nanovesicular carrier system for ocular delivery","volume":"413","author":"Kakkar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.etap.2014.04.003","article-title":"Anti-leishmanial effect of itraconazole niosome on in vitro susceptibility of Leishmania tropica","volume":"38","author":"Khazaeli","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0105","series-title":"Leishmania and Leishmaniasis","first-page":"37","author":"Kumar","year":"2013"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijantimicag.2017.01.033","article-title":"Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system","volume":"50","author":"Monteiro","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12639-016-0809-y","article-title":"The antileishmanial effects of Lowsonia inermis and Cedrus libani on Leishmania major promastigotes: an in vitro study","volume":"41","author":"Motazedian","year":"2017","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.colsurfb.2017.09.008","article-title":"A novel self-nanoemulsifying formulation for sunitinib: evaluation of anticancer efficacy","volume":"160","author":"Nazari-Vanani","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.biopha.2017.01.102","article-title":"In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin","volume":"88","author":"Nazari-Vanani","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2017.08.102","article-title":"Erlotinib-loaded albumin nanoparticles: a novel injectable form of erlotinib and its in vivo efficacy against pancreatic adenocarcinoma ASPC-1 and PANC-1 cell lines","volume":"531","author":"Noorani","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biochi.2014.06.007","article-title":"Development of antileishmanial lipid nanocomplexes","volume":"107","author":"Pham","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.actatropica.2018.05.002_bib0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jddst.2016.07.004","article-title":"Albumin coated arginine-capped magnetite nanoparticles as a paclitaxel vehicle: physicochemical characterizations and in vitro evaluation","volume":"36","author":"Sattarahmady","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0145","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.actatropica.2011.05.017","article-title":"Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole miltefosine with an immunomodulator-Picroliv","volume":"119","author":"Shakya","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/2230-973X.107002","article-title":"Formulation and evaluation of ketoconazole niosomal gel drug delivery system","volume":"2","author":"Shirsand","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0001-8686(95)00242-I","article-title":"Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry","volume":"58","author":"Uchegbu","year":"1995","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0165","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1371\/journal.pntd.0001612","article-title":"In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites","volume":"6","author":"Varela-M","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0170","doi-asserted-by":"crossref","first-page":"e0004880","DOI":"10.1371\/journal.pntd.0004880","article-title":"Efficacy and safety of AmBisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: phase II randomized trial","volume":"10","author":"Wasunna","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2018.05.002_bib0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00417211","article-title":"Efficacy of ketoconazole in cutaneous leishmaniasis","volume":"275","author":"Weinrauch","year":"1983","journal-title":"Arch. Dermatol. Res."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18303620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18303620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:11:55Z","timestamp":1757549515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X18303620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"alternative-id":["S0001706X18303620"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.05.002","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}